175 related articles for article (PubMed ID: 17295463)
21. Assessment of the putative binding conformation of a pyrazolopyridine class of inhibitors of MAPKAPK2 using computational studies.
Miglani R; Cliffe IA; Voleti SR
Eur J Med Chem; 2010 Jan; 45(1):98-105. PubMed ID: 19850376
[TBL] [Abstract][Full Text] [Related]
22. Computational analysis of R and S isoforms of 12-lipoxygenases: homology modeling and docking studies.
Aparoy P; Leela T; Reddy RN; Reddanna P
J Mol Graph Model; 2009 Feb; 27(6):744-50. PubMed ID: 19147381
[TBL] [Abstract][Full Text] [Related]
23. A three-dimensional structure of Plasmodium falciparum serine hydroxymethyltransferase in complex with glycine and 5-formyl-tetrahydrofolate. Homology modeling and molecular dynamics.
França TC; Pascutti PG; Ramalho TC; Figueroa-Villar JD
Biophys Chem; 2005 May; 115(1):1-10. PubMed ID: 15848278
[TBL] [Abstract][Full Text] [Related]
24. Protein tyrosine kinase-substrate interactions.
Bose R; Holbert MA; Pickin KA; Cole PA
Curr Opin Struct Biol; 2006 Dec; 16(6):668-75. PubMed ID: 17085043
[TBL] [Abstract][Full Text] [Related]
25. Pharmacophore modeling and in silico screening for new KDR kinase inhibitors.
Yu H; Wang Z; Zhang L; Zhang J; Huang Q
Bioorg Med Chem Lett; 2007 Apr; 17(8):2126-33. PubMed ID: 17306530
[TBL] [Abstract][Full Text] [Related]
26. Simulations of a G protein-coupled receptor homology model predict dynamic features and a ligand binding site.
Wolf S; Böckmann M; Höweler U; Schlitter J; Gerwert K
FEBS Lett; 2008 Oct; 582(23-24):3335-42. PubMed ID: 18775703
[TBL] [Abstract][Full Text] [Related]
27. Imprint of evolutionary conservation and protein structure variation on the binding function of protein tyrosine kinases.
Verkhivker GM
Bioinformatics; 2006 Aug; 22(15):1846-54. PubMed ID: 16720585
[TBL] [Abstract][Full Text] [Related]
28. Probing the structures of leishmanial farnesyl pyrophosphate synthases: homology modeling and docking studies.
Mukherjee P; Desai PV; Srivastava A; Tekwani BL; Avery MA
J Chem Inf Model; 2008 May; 48(5):1026-40. PubMed ID: 18419114
[TBL] [Abstract][Full Text] [Related]
29. Three-dimensional quantitative structure-activity relationship studies on c-Src inhibitors based on different docking methods.
Bairy SK; Suneel Kumar BV; Bhalla JU; Pramod AB; Ravikumar M
Chem Biol Drug Des; 2009 Apr; 73(4):416-27. PubMed ID: 19291104
[TBL] [Abstract][Full Text] [Related]
30. Modelling of insulin receptor tyrosine kinase in its active form: a case study for validation of theoretical methods.
Ginalski K; Wojciechowski M; Lesyng B
Acta Biochim Pol; 1999; 46(3):601-7. PubMed ID: 10698268
[TBL] [Abstract][Full Text] [Related]
31. Identification of a key element for hydrogen-bonding patterns between protein kinases and their inhibitors.
Katayama N; Orita M; Yamaguchi T; Hisamichi H; Kuromitsu S; Kurihara H; Sakashita H; Matsumoto Y; Fujita S; Niimi T
Proteins; 2008 Dec; 73(4):795-801. PubMed ID: 18767165
[TBL] [Abstract][Full Text] [Related]
32. Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of alpha-glucosidase inhibitors.
Bharatham K; Bharatham N; Park KH; Lee KW
J Mol Graph Model; 2008 Jun; 26(8):1202-12. PubMed ID: 18096420
[TBL] [Abstract][Full Text] [Related]
33. Inside the Hsp90 inhibitors binding mode through induced fit docking.
Lauria A; Ippolito M; Almerico AM
J Mol Graph Model; 2009 Feb; 27(6):712-22. PubMed ID: 19084447
[TBL] [Abstract][Full Text] [Related]
34. Structural interaction fingerprints: a new approach to organizing, mining, analyzing, and designing protein-small molecule complexes.
Singh J; Deng Z; Narale G; Chuaqui C
Chem Biol Drug Des; 2006 Jan; 67(1):5-12. PubMed ID: 16492144
[TBL] [Abstract][Full Text] [Related]
35. Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking.
Li W; Tang Y; Liu H; Cheng J; Zhu W; Jiang H
Proteins; 2008 May; 71(2):938-49. PubMed ID: 18004755
[TBL] [Abstract][Full Text] [Related]
36. Homology modeling of membrane proteins: a critical assessment.
Reddy ChS; Vijayasarathy K; Srinivas E; Sastry GM; Sastry GN
Comput Biol Chem; 2006 Apr; 30(2):120-6. PubMed ID: 16540373
[TBL] [Abstract][Full Text] [Related]
37. Molecular modeling and docking studies of glutamate racemase in Vibrio vulnificus CMCP6.
Vidya N; Vadivukkarasi B; Manivannan G; Anbarasu K
In Silico Biol; 2008; 8(5-6):471-83. PubMed ID: 19374132
[TBL] [Abstract][Full Text] [Related]
38. Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model.
Li S; Zhou Y; Lu W; Zhong Y; Song W; Liu K; Huang J; Zhao Z; Xu Y; Liu X; Li H
J Chem Inf Model; 2011 Nov; 51(11):2939-47. PubMed ID: 21995341
[TBL] [Abstract][Full Text] [Related]
39. A model of 3D-structure of H+, K+-ATPase catalytic subunit derived by homology modeling.
Yan D; Hu YD; Li S; Cheng MS
Acta Pharmacol Sin; 2004 Apr; 25(4):474-9. PubMed ID: 15066216
[TBL] [Abstract][Full Text] [Related]
40. Molecular modeling and crystal structure of ERK2-hypothemycin complexes.
Rastelli G; Rosenfeld R; Reid R; Santi DV
J Struct Biol; 2008 Oct; 164(1):18-23. PubMed ID: 18571434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
